Global Inactivated Vaccines Market Research Report 2021

Global Inactivated Vaccines Market Research Report 2021

1 Inactivated Vaccines Overview

1.1 Product Overview and Scope of Inactivated Vaccines

1.2 Inactivated Vaccines Segment by Types

1.2.1 Global Sales Market Share of Inactivated Vaccines by Type in 2015

1.2.2 Pneumococcal

1.2.3 Influenza

1.2.4 HPV

1.2.5 Hepatitis

1.2.6 Rotavirus

1.2.7 DTP

1.2.8 Polio

1.2.9 MMR

1.3 Inactivated Vaccines Segment by Applications

1.3.1 Pediatric

1.3.2 Adult

1.3.3 Application 3

1.4 Inactivated Vaccines Market by Regions

1.4.1 North America Status and Prospect (2011-2021)

1.4.2 China Status and Prospect (2011-2021)

1.4.3 Europe Status and Prospect (2011-2021)

1.4.4 Japan Status and Prospect (2011-2021)

1.4.5 India Status and Prospect (2011-2021)

1.4.6 Southeast Asia Status and Prospect (2011-2021)

1.5 Global Market Size (Value and Volume) of Inactivated Vaccines (2011-2021)

1.5.1 Global Inactivated Vaccines Sales and Revenue (2011-2021)

1.5.2 Global Inactivated Vaccines Sales and Growth Rate (2011-2021)

1.5.3 Global Inactivated Vaccines Revenue and Growth Rate (2011-2021)

2 Global Inactivated Vaccines Market Competition by Manufacturers

2.1 Global Inactivated Vaccines Sales and Share by Manufacturers (2015 and 2016)

2.2 Global Inactivated Vaccines Revenue and Share by Manufacturers (2015 and 2016)

2.3 Manufacturers Inactivated Vaccines Manufacturing Base Distribution and Product Type

2.4 Competitive Situation and Trends

2.4.1 Expansions

2.4.2 New Product Launches

2.4.3 Acquisitions

2.4.4 Other Developments

3 Global Inactivated Vaccines Analysis by Region

3.1 Global Inactivated Vaccines Sales, Revenue and Market Share by Region (2011-2021)

3.1.1 Global Inactivated Vaccines Sales Market Share by Region (2011-2021)

3.1.2 Global Inactivated Vaccines Revenue Market Share by Region (2011-2021)

3.2 North America

3.2.1 North America Inactivated Vaccines Sales, Revenue and Price (2011-2021)

3.2.2 North America Inactivated Vaccines Sales, Revenue and Growth Rate (2011-2021)

3.3 Europe

3.3.1 Europe Inactivated Vaccines Sales, Revenue and Price (2011-2021)

3.3.2 Europe Inactivated Vaccines Sales, Revenue and Growth Rate (2011-2021)

3.4 China

3.4.1 China Inactivated Vaccines Sales, Revenue and Price (2011-2021)

3.4.2 China Inactivated Vaccines Sales, Revenue and Growth Rate (2011-2021)

3.5 Japan

3.5.1 Japan Inactivated Vaccines Sales, Revenue and Price (2011-2021)

3.5.2 Japan Inactivated Vaccines Sales, Revenue and Growth Rate (2011-2021)

3.6 India

3.6.1 India Inactivated Vaccines Sales, Revenue and Price (2011-2021)

3.6.2 India Inactivated Vaccines Sales, Revenue and Growth Rate (2011-2021)

3.7 Southeast Asia

3.7.1 Southeast Asia Inactivated Vaccines Sales, Revenue and Price (2011-2021)

3.7.2 Southeast Asia Inactivated Vaccines Sales, Revenue and Growth Rate (2011-2021)

4 Global Inactivated Vaccines Analysis by Type

4.1 Global Inactivated Vaccines Sales, Revenue, Market Share and Growth Rate by Type (2011-2021)

4.1.1 Global Inactivated Vaccines Sales and Market Share by Type (2011-2021)

4.1.2 Global Inactivated Vaccines Revenue, Market Share and Growth Rate by Type (2011-2021)

4.2 Pneumococcal Sales, Revenue, Price and Growth (2011-2021)

4.3 Influenza Sales, Revenue, Price and Growth (2011-2021)

4.4 HPV Sales, Revenue, Price and Growth (2011-2021)

4.5 Hepatitis Sales, Revenue, Price and Growth (2011-2021)

4.6 Rotavirus Sales, Revenue, Price and Growth (2011-2021)

4.7 DTP Sales, Revenue, Price and Growth (2011-2021)

4.8 Polio Sales, Revenue, Price and Growth (2011-2021)

4.9 MMR Sales, Revenue, Price and Growth (2011-2021)

5 Global Inactivated Vaccines Market Analysis by Application

5.1 Global Inactivated Vaccines Sales and Market Share by Application (2011-2021)

5.2 Major Regions Inactivated Vaccines Sales by Application in 2015 and 2016

5.2.1 North America Inactivated Vaccines Sales by Application

5.2.2 Europe Inactivated Vaccines Sales by Application

5.2.3 China Inactivated Vaccines Sales by Application

5.2.4 Japan Inactivated Vaccines Sales by Application

5.2.5 India Inactivated Vaccines Sales by Application

5.2.6 Southeast Asia Inactivated Vaccines Sales by Application

6 Global Inactivated Vaccines Manufacturers Analysis

6.1 Astellas Pharma Inc

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Inactivated Vaccines Product Overview

6.1.2.1 Pneumococcal

6.1.2.2 Influenza

6.1.2.3 HPV

6.1.3 Inactivated Vaccines Sales, Revenue, Price of Astellas Pharma Inc (2015 and 2016)

6.2 CSL Limited

6.2.1 Company Basic Information, Manufacturing Base and Competitors

6.2.2 Inactivated Vaccines Product Overview

6.2.2.1 Pneumococcal

6.2.2.2 Influenza

6.2.2.3 HPV

6.2.3 Inactivated Vaccines Sales, Revenue, Price of CSL Limited (2015 and 2016)

6.3 Emergent BioSolutions, Inc

6.3.1 Company Basic Information, Manufacturing Base and Competitors

6.3.2 Inactivated Vaccines Product Overview

6.3.2.1 Pneumococcal

6.3.2.2 Influenza

6.3.2.3 HPV

6.3.3 Inactivated Vaccines Sales, Revenue, Price of Emergent BioSolutions, Inc (2015 and 2016)

6.4 GlaxoSmithKline

6.4.1 Company Basic Information, Manufacturing Base and Competitors

6.4.2 Inactivated Vaccines Product Overview

6.4.2.1 Pneumococcal

6.4.2.2 Influenza

6.4.3 Inactivated Vaccines Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)

6.5 Johnson & Johnson

6.5.1 Company Basic Information, Manufacturing Base and Competitors

6.5.2 Inactivated Vaccines Product Overview

6.5.2.1 Pneumococcal

6.5.2.2 Influenza

6.5.3 Inactivated Vaccines Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)

6.6 MedImmune, LLC

6.6.1 Company Basic Information, Manufacturing Base and Competitors

6.6.2 Inactivated Vaccines Product Overview

6.6.2.1 Pneumococcal

6.6.2.2 Influenza

6.6.3 Inactivated Vaccines Sales, Revenue, Price of MedImmune, LLC (2015 and 2016)

6.7 Merck & Co

6.7.1 Company Basic Information, Manufacturing Base and Competitors

6.7.2 Inactivated Vaccines Product Overview

6.7.2.1 Pneumococcal

6.7.2.2 Influenza

6.7.3 Inactivated Vaccines Sales, Revenue, Price of Merck & Co (2015 and 2016)

6.8 Pfizer

6.8.1 Company Basic Information, Manufacturing Base and Competitors

6.8.2 Inactivated Vaccines Product Overview

6.8.2.1 Pneumococcal

6.8.2.2 Influenza

6.8.3 Inactivated Vaccines Sales, Revenue, Price of Pfizer (2015 and 2016)

6.9 Sanofi Pasteur

6.9.1 Company Basic Information, Manufacturing Base and Competitors

6.9.2 Inactivated Vaccines Product Overview

6.9.2.1 Pneumococcal

6.9.2.2 Influenza

6.9.3 Inactivated Vaccines Sales, Revenue, Price of Sanofi Pasteur (2015 and 2016)

6.10 Serum Institute

6.10.1 Company Basic Information, Manufacturing Base and Competitors

6.10.2 Inactivated Vaccines Product Overview

6.10.2.1 Pneumococcal

6.10.2.2 Influenza

6.10.3 Inactivated Vaccines Sales, Revenue, Price of Serum Institute (2015 and 2016)

6.11 India Pvt. Ltd. (India)

7 Industry Policy Analysis

8 Research Findings and Conclusion

Figure Picture of Inactivated Vaccines

Figure Global Sales Market Share of Inactivated Vaccines by Type in 2015

Table Inactivated Vaccines Product Type of by Manufacturers

Table Inactivated Vaccines Sales Market Share by Application in 2015 and 2016

Figure North America Inactivated Vaccines Revenue and Growth Rate (2011-2021)

Figure China Inactivated Vaccines Revenue and Growth Rate (2011-2021)

Figure Europe Inactivated Vaccines Revenue and Growth Rate (2011-2021)

Figure Japan Inactivated Vaccines Revenue and Growth Rate (2011-2021)

Figure India Inactivated Vaccines Revenue and Growth Rate (2011-2021)

Figure Southeast Asia Inactivated Vaccines Revenue and Growth Rate (2011-2021)

Table Global Inactivated Vaccines Sales and Revenue (2011-2021)

Figure Global Inactivated Vaccines Sales and Growth Rate (2011-2021)

Figure Global Inactivated Vaccines Revenue and Growth Rate (2011-2021)

Table Global Inactivated Vaccines Sales of Key Manufacturers (2015 and 2016)

Table Global Inactivated Vaccines Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Inactivated Vaccines Sales Share by Manufacturers

Figure 2016 Inactivated Vaccines Sales Share by Manufacturers

Table Global Inactivated Vaccines Revenue by Manufacturers (2015 and 2016)

Table Global Inactivated Vaccines Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Global Inactivated Vaccines Revenue Share by Manufacturers

Table 2016 Global Inactivated Vaccines Revenue Share by Manufacturers

Table Manufacturers Inactivated Vaccines Manufacturing Base Distribution and Product Type

Table Global Inactivated Vaccines Sales Market by Region (2011-2021)

Figure Global Inactivated Vaccines Sales Market by Region (2011-2021)

Figure Global Inactivated Vaccines Sales Market Share by Region (2011-2021)

Table Global Inactivated Vaccines Revenue Market by Region (2011-2021)

Table Global Inactivated Vaccines Revenue Market Share by Region (2011-2021)

Table North America Inactivated Vaccines Sales, Revenue and Price (2011-2021)

Figure North America Inactivated Vaccines Sales, Revenue and Growth Rate (2011-2021)

Table Europe Inactivated Vaccines Sales, Revenue and Price (2011-2021)

Figure Europe Inactivated Vaccines Sales, Revenue and Growth Rate (2011-2021)

Table China Inactivated Vaccines Sales, Revenue and Price (2011-2021)

Figure China Inactivated Vaccines Sales, Revenue and Growth Rate (2011-2021)

Table Japan Inactivated Vaccines Sales, Revenue and Price (2011-2021)

Figure Japan Inactivated Vaccines Sales, Revenue and Growth Rate (2011-2021)

Table India Inactivated Vaccines Sales, Revenue and Price (2011-2021)

Figure India Inactivated Vaccines Sales, Revenue and Growth Rate (2011-2021)

Table Southeast Asia Inactivated Vaccines Sales, Revenue and Price (2011-2021)

Figure Southeast Asia Inactivated Vaccines Sales, Revenue and Growth Rate (2011-2021)

Table Global Inactivated Vaccines Sales by Type (2011-2021)

Table Global Inactivated Vaccines Sales Share by Type (2011-2021)

Figure Sales Market Share of Inactivated Vaccines by Type (2011-2021)

Figure Global Inactivated Vaccines Sales Growth Rate by Type (2011-2021)

Table Global Inactivated Vaccines Revenue by Type (2011-2021)

Table Global Inactivated Vaccines Revenue Share by Type (2011-2021)

Figure Global Inactivated Vaccines Revenue Growth Rate by Type (2011-2021)

Figure Pneumococcal Sales, Revenue and Growth (2011-2021)

Figure Pneumococcal Price Trend (2011-2021)

Figure Influenza Sales, Revenue and Growth (2011-2021)

Figure Influenza Price Trend (2011-2021)

Figure HPV Sales, Revenue and Growth (2011-2021)

Figure HPV Price Trend (2011-2021)

Figure Hepatitis Sales, Revenue and Growth (2011-2021)

Figure Hepatitis Price Trend (2011-2021)

Figure Rotavirus Sales, Revenue and Growth (2011-2021)

Figure Rotavirus Price Trend (2011-2021)

Figure DTP Sales, Revenue and Growth (2011-2021)

Figure DTP Price Trend (2011-2021)

Figure Polio Sales, Revenue and Growth (2011-2021)

Figure Polio Price Trend (2011-2021)

Figure MMR Sales, Revenue and Growth (2011-2021)

Figure MMR Price Trend (2011-2021)

Table Global Inactivated Vaccines Sales by Application (2011-2021)

Table Global Inactivated Vaccines Sales Market Share by Application (2011-2021)

Figure Global Inactivated Vaccines Sales Market Share by Application in 2015

Figure Global Inactivated Vaccines Sales Market Share by Application in 2021

Table North America Inactivated Vaccines Sales by Application (2015 and 2016)

Table Europe Inactivated Vaccines Sales by Application (2015 and 2016)

Table China Inactivated Vaccines Sales by Application (2015 and 2016)

Table Japan Inactivated Vaccines Sales by Application (2015 and 2016)

Table India Inactivated Vaccines Sales by Application (2015 and 2016)

Table Southeast Asia Inactivated Vaccines Sales by Application (2015 and 2016)

Table Global Inactivated Vaccines Sales Growth Rate by Application (2011-2021)

Figure Global Inactivated Vaccines Sales Growth Rate by Application (2011-2021)

Table Astellas Pharma Inc Basic Information List

Table Inactivated Vaccines Sales, Revenue, Price of Astellas Pharma Inc (2015 and 2016)

Table CSL Limited Basic Information List

Table Inactivated Vaccines Sales, Revenue, Price of CSL Limited (2015 and 2016)

Table Emergent BioSolutions, Inc Basic Information List

Table Inactivated Vaccines Sales, Revenue, Price of Emergent BioSolutions, Inc (2015 and 2016)

Table GlaxoSmithKline Basic Information List

Table Inactivated Vaccines Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)

Table Johnson & Johnson Basic Information List

Table Inactivated Vaccines Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)

Table MedImmune, LLC Basic Information List

Table Inactivated Vaccines Sales, Revenue, Price of MedImmune, LLC (2015 and 2016)

Table Merck & Co Basic Information List

Table Inactivated Vaccines Sales, Revenue, Price of Merck & Co (2015 and 2016)

Table Pfizer Basic Information List

Table Inactivated Vaccines Sales, Revenue, Price of Pfizer (2015 and 2016)

Table Sanofi Pasteur Basic Information List

Table Inactivated Vaccines Sales, Revenue, Price of Sanofi Pasteur (2015 and 2016)

Table Serum Institute Basic Information List

Table Inactivated Vaccines Sales, Revenue, Price of Serum Institute (2015 and 2016)

Table India Pvt. Ltd. (India) Basic Information List

Table Inactivated Vaccines Sales, Revenue, Price of India Pvt. Ltd. (India) (2015 and 2016)